Local blood center officials announced a significant change in their pre-screening process: the elimination of finger pricks. The center has implemented a new, non-invasive testing device called OrSense, streamlining the initial assessment for potential donors.

Previously, potential donors underwent a routine finger prick to obtain a small blood sample for preliminary testing. This process, while standard, could be perceived as uncomfortable by some. The introduction of OrSense technology allows for hemoglobin measurement and other key indicators to be assessed without drawing blood.

OrSense utilizes near-infrared spectroscopy to analyze blood through the skin. This method provides results comparable to traditional finger prick testing, but without the need for needles. The technology has been gaining traction in healthcare settings for its convenience and patient-friendly approach.

“We are committed to providing a comfortable and convenient donation experience,” said a spokesperson for the blood center. “The OrSense device allows us to achieve this while maintaining the accuracy and reliability of our pre-screening process.”

The blood center anticipates that this change will encourage more individuals to consider donating blood, further supporting the region’s blood supply. The implementation of OrSense is part of the center’s ongoing efforts to adopt innovative technologies and improve donor experience. Further details regarding the new process are available on the blood center’s website.